AVR 4.08% $12.49 anteris technologies ltd

Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-150

  1. 238 Posts.
    lightbulb Created with Sketch. 106
    Have to wonder why so many people are selling, just doesn't make sense to me. The lights are on for the immediate future, there doesn't seem to be *much* scope for bad news, any good news is going to be handsomely rewarded considering the bargain-basement SP, and overall everything's looking a lot more positive - or less negative - than it has in a very long time. So it seems like it's largely upside for at least the next two quarters, with very little to gain from selling now.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.